Interim Results From A Phase Ii Clinical Study Of Tislelizumab Combined With Gemcitabine And Cisplatin As A Bladder-Sparing Therapy For Urine Tumor Dna (Utdna) Defined Clinical Complete Response (Ccr) Mibc Patients
Cisplatin;Gemcitabine;Tislelizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Interim Results From A Phase Ii Clinical Study Of Tislelizumab Combined With Gemcitabine And Cisplatin As A Bladder-Sparing Therapy For Urine Tumor Dna (Utdna) Defined Clinical Complete Response (Ccr) Mibc Patients ### Output: Cisplatin;Gemcitabine;Tislelizumab